Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Song, Ga-Young | - |
dc.contributor.author | Jung, Sung-Hoon | - |
dc.contributor.author | Lee, Je-Jung | - |
dc.contributor.author | Kim, Jin Seok | - |
dc.contributor.author | Min, Chang-Ki | - |
dc.contributor.author | Kim, Kihyun | - |
dc.contributor.author | Choi, Yunsuk | - |
dc.contributor.author | Eom, Hyeon-Seok | - |
dc.contributor.author | Joo, Young Don | - |
dc.contributor.author | Kim, Sung-Hyun | - |
dc.contributor.author | Kwak, Jae-Yong | - |
dc.contributor.author | Kang, Hye Jin | - |
dc.contributor.author | Lee, Jae Hoon | - |
dc.contributor.author | Lee, Ho Sup | - |
dc.contributor.author | Mun, Yeung-Chul | - |
dc.contributor.author | Moon, Joon Ho | - |
dc.contributor.author | Sohn, Sang Kyun | - |
dc.contributor.author | Park, Seong Kyu | - |
dc.contributor.author | Park, Yong | - |
dc.contributor.author | Shin, Ho-Jin | - |
dc.contributor.author | Yoon, Sung-Soo | - |
dc.date.accessioned | 2021-08-30T14:02:01Z | - |
dc.date.available | 2021-08-30T14:02:01Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-09-18 | - |
dc.identifier.issn | 1042-8194 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/53134 | - |
dc.description.abstract | We compared the efficacy and toxicity of busulfan and melphalan (BUMEL) and those of high-dose melphalan (HDMEL) as conditioning regimens for autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM) through a propensity score-matched analysis. No significant difference in the complete response and overall response rate after ASCT was observed between BUMEL and HDMEL. After a median follow-up of 37.3 months in the BUMEL group and 50.8 months in the HDMEL group, the median progression-free survival was calculated to be 32.9 months and 25.2 months (p = 0.995). With respect to non-hematologic toxicities, infections were more frequently reported in the BUMEL group (p < 0.001). Three patients who received BUMEL developed veno-occlusive disease (VOD), and all of them recovered without administration of defibrotide. In conclusion, BUMEL is an effective alternative conditioning regimen in terms of efficacy, but attention should be paid to toxicities. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.subject | MINIMAL RESIDUAL DISEASE | - |
dc.subject | MARROW-TRANSPLANTATION | - |
dc.subject | VENOOCCLUSIVE DISEASE | - |
dc.subject | LIVER | - |
dc.title | Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park, Yong | - |
dc.identifier.doi | 10.1080/10428194.2020.1783448 | - |
dc.identifier.scopusid | 2-s2.0-85087449806 | - |
dc.identifier.wosid | 000547986700001 | - |
dc.identifier.bibliographicCitation | LEUKEMIA & LYMPHOMA, v.61, no.11, pp.2714 - 2721 | - |
dc.relation.isPartOf | LEUKEMIA & LYMPHOMA | - |
dc.citation.title | LEUKEMIA & LYMPHOMA | - |
dc.citation.volume | 61 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 2714 | - |
dc.citation.endPage | 2721 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Hematology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Hematology | - |
dc.subject.keywordPlus | MINIMAL RESIDUAL DISEASE | - |
dc.subject.keywordPlus | MARROW-TRANSPLANTATION | - |
dc.subject.keywordPlus | VENOOCCLUSIVE DISEASE | - |
dc.subject.keywordPlus | LIVER | - |
dc.subject.keywordAuthor | Multiple myeloma | - |
dc.subject.keywordAuthor | conditioning regimen | - |
dc.subject.keywordAuthor | autologous stem cell transplantation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.